1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Kadence Bio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (LPE) KH-001 ODT, Placebo ODT - Premature Ejaculation | Phase 2 | Recruiting | Kadence Bio | 40 | 2025-12-01 | 2026-08-12 |
| A Phase I Study to Investigate KH-001 in Healthy Males KH-001 besylate, KH-001 besylate placebo - Healthy Male Volunteers | Phase 1 | Completed | Kadence Bio | 82 | 2023-11-14 | 2026-10-09 |
Australia (1) · United Kingdom (1)
2023 (1)